sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Metastatic Cancer Drug Market Scope And Analysis

  • Report Code : TIPRE00028616
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 233
Buy Now

Metastatic Cancer Drug Market Analysis and Scope 2021-2031

Buy Now

Metastatic Cancer Drug Market Report Metastatic Cancer Drug Market Size and Share Metastatic Cancer Drug Market Scope and Analysis

Metastatic Cancer Drug Market Report Scope

Report Attribute Details
Market size in 2021 US$ 51.16 Billion
Market Size by 2028 US$ 68.35 Billion
Global CAGR (2021 - 2028) 4.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Cancer Type
  • Breast Cancer
  • Lung Cancer
  • Liver Cancer
  • Hematological Cancer
  • Brain Cancer
  • Prostate Cancer
  • Pancreatic Cancer
By Route of Administration
  • Intravenous
  • Intramuscular
  • Oral
By Drug Class
  • HER2 Inhibitor
  • Immune Checkpoint Inhibitor
  • PARP Inhibitor
  • Kinase Inhibitor
By Product
  • Branded and Generic & Biosimilar
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc
  • Amgen Inc
  • Bristol Myers Squibb Company
  • F HOFFMANN LA ROCHE LTD
  • Novartis AG
  • ASTRAZENECA PLC
  • Eli Lilly and Company
  • MERCK KGaA
  • Pfizer Inc Arena Pharmaceutical GmbH